icon

DeepChek® Assay Integrase Genotyping and Drug Resistance

An HIV-1 integrase assay that amplifies the INT region of the pol open reading frame to support integrase-resistance analysis.

HIV Genotyping & Drug Resistance

Integrase Genotyping

CE-IVDRUO

The integrase assay targets codons 20 to 280 of the HIV-1 integrase gene from extracted RNA, with support for NGS and Sanger sequencing report workflows.

Sequencing workflow HIV-1 DeepChek portfolio
DeepChek Assay Integrase Genotyping and Drug Resistance

Key Details

  • Amplifies a relevant HIV-1 integrase gene portion from plasma, serum, or whole blood sample RNA.
  • Covers codons 20 to 280 of the INT gene in the pol open reading frame.
  • Can aid in the determination of antiviral resistance in HIV-infected clinical samples.
  • Positioned as an integrase-focused companion to PR/RT genotyping workflows.

Workflow Snapshot

Target regionIntegrase, codons 20 to 280
Sample inputExtracted RNA from plasma, serum, or whole blood
NGS reportingDeepChek-HIV CE-IVD
Sanger reportingViroScore-HIV CE-IVD

Ordering Information

ProductReference
DeepChek Assay Integrase Genotyping and Drug Resistance (CE-IVD)122A24
DeepChek Assay Integrase Genotyping and Drug Resistance (RUO)102C24
DeepChek HIV Software (CE-IVD)S-12-023 (HL)
ViroScore-HIV Annual Software License (CE-IVD)S-09-014

Implementation Note

Use this assay when integrase resistance markers need dedicated coverage alongside existing HIV genotyping workflows.

Back To HIV Portfolio

Related HIV Assays